Eiropas Savienība - latviešu - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiski līdzekļi - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multiple mieloma - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostatas audzēji - citi hormonu antagonisti un tiem līdzīgas vielas - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Latvija - latviešu - Zāļu valsts aģentūra

stada arzneimittel ag, germany - meloksikāms - tablete - 7,5 mg

Latvija - latviešu - Zāļu valsts aģentūra

stada arzneimittel ag, germany - meloksikāms - tablete - 15 mg

Latvija - latviešu - Zāļu valsts aģentūra

teva pharma b.v., netherlands - alfuzosīna hidrohlorīds - ilgstošās darbības tablete - 10 mg

Latvija - latviešu - Zāļu valsts aģentūra

teva pharma b.v., netherlands - finasterīds - apvalkotā tablete - 5 mg

Latvija - latviešu - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - finasterīds - apvalkotā tablete - 5 mg

Latvija - latviešu - Zāļu valsts aģentūra

linepharma international limited, united kingdom - mifepristons - tablete - 200 mg

Latvija - latviešu - Zāļu valsts aģentūra

accord healthcare b.v., netherlands - finasterīds - apvalkotā tablete - 1 mg